(Q54297545)

27 May 2018

title

Cytokines and insulin resistance after zoledronic acid-induced acute phase response. (English)

1 reference

27 May 2018

1 reference

Georgia Kassi

1

1 reference

27 May 2018

Konstantinos Papamichael

2

1 reference

27 May 2018

Garyfallia Papaioannou

3

1 reference

27 May 2018

Irene Giagourta

4

1 reference

27 May 2018

Stavroula Thanou

5

1 reference

27 May 2018

Maria Triantaphyllopoulou

6

1 reference

27 May 2018

Evagelia Zapanti

7

1 reference

27 May 2018

Fotini Papandroulaki

8

1 reference

27 May 2018

Vasiliki Ktena

9

1 reference

27 May 2018

Helen Karga

10

1 reference

27 May 2018

publication date

24 March 2014

1 reference

27 May 2018

Immunological Investigations

published in

1 reference

27 May 2018

volume

43

1 reference

27 May 2018

issue

6

1 reference

27 May 2018

page(s)

544-555

1 reference

27 May 2018

Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass.

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Resistin is associated with biomarkers of inflammation while total and high-molecular weight adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Systemic blockade of TNF-α does not improve insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Sepsis-Induced Adipokine Change with regard to Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

An inflammatory cascade leading to hyperresistinemia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Diagnosing insulin resistance in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Experimental endotoxemia induces adipose inflammation and insulin resistance in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

What is the optimal duration of bisphosphonate therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Direct antidiabetic effect of leptin through triglyceride depletion of tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Adipose tissue-derived factors: impact on health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Glucose metabolism and insulin resistance in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Human leptin: from an adipocyte hormone to an endocrine mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Role of reactive oxygen species in injury-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820139.2014.892510

10.3109/08820139.2014.892510

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

release_jrjbo7bgqneazoj7nu4nhxe3hq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jrjbo7bgqneazoj7nu4nhxe3hq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

27 May 2018